NPS's Nader on Drug Research, Growth Strategy

Feb. 25 (Bloomberg) -- Francois Nader, chief excutive officer for NPS Pharmaceuticals Inc., talks about cost strategy and product development. Nader speaks with Sara Eisen and Tom Keene on Bloomberg Television's "Surveillance." Stanley Collender, managing director for Qorvis Communications LLC, also speaks. (Source: Bloomberg)
Jackson Hole, Jefferies, Munis: What's Moving Markets
58:41 - Sam Stovall, managing director of U.S. equity strategy at Standard & Poor's, joins Bloomberg’s Matt Miller and Mike Regan to run down the three things you need to know about today’s market. They speak on “Market Makers.” (Source: Bloomberg)
  • Fed's Kocherlakota Sees Ways to Lower Rates Further
  • Mester: Reasonably Confident Inflation Gets Back to 2%
  • Oil Price Rebound: Fundamentals or Short Covering?